1. Home
  2. NEPH vs BAFN Comparison

NEPH vs BAFN Comparison

Compare NEPH & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.49

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$6.69

Market Cap

26.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
BAFN
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
26.6M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
NEPH
BAFN
Price
$3.49
$6.69
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
20.5K
59.1K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
1.00%
EPS Growth
1000.00
N/A
EPS
0.01
N/A
Revenue
$18,789,000.00
N/A
Revenue This Year
$11.24
N/A
Revenue Next Year
$11.58
N/A
P/E Ratio
$28.41
N/A
Revenue Growth
32.67
N/A
52 Week Low
$2.05
$4.80
52 Week High
$6.42
$16.35

Technical Indicators

Market Signals
Indicator
NEPH
BAFN
Relative Strength Index (RSI) 60.66 44.73
Support Level $2.77 $5.73
Resistance Level $4.92 $7.08
Average True Range (ATR) 0.29 0.83
MACD 0.05 -0.16
Stochastic Oscillator 63.84 37.02

Price Performance

Historical Comparison
NEPH
BAFN

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: